Overview
WARNING: As this organisation lists one or more EP accredited lobbyists, it may not be probable that its lobbying costs are lower than €10,000.
Lobbying Costs
10,000€ - 24,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
0.75 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
2
Lobbying Costs over the years
-
Info
Panhellenic Union of Pharmaceutical Industry (PEF)
EU Transparency Register
336263411883-56 First registered on 16 Sep 2013
Goals / Remit
The PanHellenic Union of Pharmaceutical Industry (PEF) represents domestic pharmaceutical manufacturers in Greece. Our association currently has 52 member companies which operate in the Greek market with 38 production sites in Greece, which develop and produce mainly branded generics, strictly in line with the high quality standards of the EMA and FDA. The Greek pharmaceutical industry has been implementing major investment programs in infrastructure and in process / quality control systems. Within this context, PEFs' main goals and scope of activities at EU level are to develop and maintain a constructive dialogue with EU institutions in order to understand and participate in health policy developments that affect and impact the Greek pharmaceutical industry as well as strengthen the competitiveness of the European pharmaceutical industry as a whole.
Main EU files targeted
The Panhellenic Union of Pharmaceutical Industry actively follows legislative files discussed at EU level and follow the legislative process by monitoring the European Commission and European Parliament Committees. In the past, the files that were monitored were SPC, EMA regulations and Horizon funding opportunities. In light of the COVID-19 pandemic and the aftershock effects on healthcare systems around Europe, PEF is actively involved in policy developments regarding the EU pharmaceutical Strategy, the review of the pharmaceutical legislation as well as the IP Action Plan. We try to keep up to date with EU Funding Initiatives and attend as far as possible info days and events supported or organized by the Commission in Brussels or in Greece. Further policies developed under the Green Deal such as the Urban Waste Water Treatment Directives, the FGas Regulation and the Packaging and Packaging waste Regulation are also files that have direct impact on our industry and as such we have followed the entire legislative process of these files.
Address
Head Office
Kifisias Avenue 324-326
Athens 15451
GREECEEU Office
Kifisias Avenue 324-326
Athens 15451
GREECEWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 75% 1 Lobbyists (Full time equivalent)
0.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 14 Sep 2024
Name Start date End Date Ms Aikaterini Patavou 05 Apr 2017 04 Apr 2018 Ms Aikaterini Patavou 13 Feb 2016 11 Feb 2017 Mr Theodoros Tryfon 07 Mar 2015 05 Mar 2016 Ms Aikaterini Patavou 02 Sep 2014 27 Aug 2015 Ms Foteini Kosmopoulou 02 Sep 2014 27 Aug 2015 Ms Aikaterini Patavou 20 Sep 2013 02 Sep 2014 Complementary Information
PEF has one person in charge of all EU relations. Ms Patavou is Head of EU Public Affairs and monitors all developments dealing with EU legislations.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
The Panhellenic Union of Pharmaceutical Industry is a member of Medicines for Europe since 2018, the European Association representing generics, biosimilar and value added medicines. www.medicinesforeurope.com
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
10,000€ - 24,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
10,000€ - 24,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
The Panhellenic Union of Pharmaceutical Industry actively tries to follow policy discussions by attending any public events or committee meetings in the European Parliament. We share our position on active files and European level discussions regarding issues that affect our sector and provide our expertise regarding the impact of such measures may have on health systems, healthcare industry and patients. We are also a member of the Medicines for Europe since 2018 and as such we follow and support with our own input into our European Associations communication activities. At a national level we organise workshops and seminars to familiarize and increase awareness on the impact and changes that new EU policies may have to our member companies.
Other activities
None declared
Meetings
Meetings
2 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 15 Jul 2022 Location Thessaloniki Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
-
Date 08 Oct 2021 Location Athens Subject Pharma policies Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Krikou (Cabinet member)
- Margaritis Schinas (Vice-President)